Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening
An at-home spit test appears to perform better at predicting prostate cancer risk than the current frontline test, a study suggests.
The test assesses 130 genetic variants to provide a risk score for prostate cancer, which is the second most common cause of cancer deaths in men in the UK.
More Stories
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
European journalists targeted with Paragon Solutions spyware, say researchers
UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment